The C7 gene makes a protein that helps your immune system form the membrane attack complex, a structure that can break open certain bacteria. This gene helps your body finish one of its fast defense steps against germs, especially Neisseria bacteria. If the C7 gene does not work properly, you may be more likely to get repeated infections such as meningococcal disease. Many people are otherwise well between infections, and the main clue is unusual or recurrent infections rather than everyday symptoms.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. More detailed information on this topic is available in the LearnHub.
Overview
C7Gene function
What if the gene works
The C7 gene helps your immune system kill certain bacteria. It provides one part of the membrane attack complex, which helps make tiny holes in germs so the body can clear them.
Risk
What if the gene does not work
Variants in the C7 gene can weaken a key immune defense, raising the chance of recurrent Neisseria infections, especially meningococcal disease. Milder and more severe variants may affect when infections begin and how often they happen.
Treatment
What does that mean for your treatment
For people with a pathogenic loss-of-function variant in the C7 gene, care usually centers on reducing meningococcal infection risk. Management commonly includes meningococcal vaccination, and some may also need preventive antibiotics or rapid antibiotic treatment if fever or suspected infection develops.
Conditions associated with C7
Gene function
What if the gene works
Your body uses instructions in the C7 gene as part of a fast, built in defense system in the blood. Understanding how the C7 gene supports the immune system is easier if you picture immune proteins assembling on the surface of a germ. This process helps your body damage and clear certain bacteria.
C7 makes a protein that circulates in the blood as part of complement, a group of immune proteins that helps fight germs. It stays ready until other complement proteins trigger the final stage of this defense response.
Once this response is underway, the C7 protein joins partner proteins and helps the complex attach to a germ's outer surface. This moves the attack from the bloodstream onto the microbe itself.
After attachment, C7 helps bring in more complement proteins, especially C8 and C9. Together they create a tiny opening in the germ's surface, which helps your body control certain bacteria.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence of a gene. These changes are common and are one reason people naturally differ in features such as appearance, metabolism, and the body’s response to environmental influences. Many do not lead to any noticeable effect and are simply part of normal genetic variation. In some cases, though, a variant may affect gene function more strongly and can contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
In many people, how C7 gene variants affect protein function depends on the type of DNA change in the C7 gene. Some variants alter the protein’s shape, make it unstable, or stop it from being released into the blood, while more disruptive variants can shorten it early so little or no working C7 is made. Milder variants may leave partial activity, but stronger loss of function often leads to a more complete C7 deficiency and can be linked to earlier or more frequent infections.
How variants are linked to conditions
Pathogenic variants in the C7 gene can cause complement component 7 deficiency, a rare inherited immune condition. People with this diagnosis have a higher chance of recurrent infections caused by Neisseria bacteria, especially meningococcal disease. In discussions of C7 gene variants and related conditions, this is the main link supported by human genetics studies. Carriers of one altered copy usually do not develop the condition.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead represent natural variation among people. For many genes, carrying a variant linked to a condition indicates a possible association rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in the C7 gene, the main health risk is serious infection, especially meningococcal infection, and that risk is mostly driven by the gene change itself. Exposure during outbreaks, close contact with someone who is infected, or living in shared housing can raise infection risk. Vaccination and fast treatment of fever or severe illness can help lower the chance of dangerous complications.
Inheritance of C7 variants
For people reading about inheritance of C7 gene variants, the well-established pattern is autosomal recessive. This means a person usually develops C7 deficiency only if they inherit two disease-causing variants in the C7 gene, one from each parent. Parents who each carry one variant are typically healthy carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. Sons and daughters are affected at similar rates.
What does my C7 result mean for my family?
For families with a disease-causing change in the C7 gene, close relatives may also carry the same change or, less often, have the condition themselves. In families affected by C7-related complement deficiency, brothers, sisters, and future children can be the relatives most likely to share this result. Parents are often healthy carriers, and other blood relatives may also be carriers.
Genetic information
Genetic testing
How you find out about variants
To check for a variant in the C7 gene, genetic testing for C7 variants analyzes DNA from blood or saliva. Labs usually read the gene’s sequence and may also look for missing or extra pieces. Results may show no relevant variant, a known C7 variant, or a finding that needs more interpretation.
When should I consider getting a genetic test?
Consider testing the C7 gene if someone has had repeated meningococcal infections, especially more than once or at a young age, or if blood tests suggest a problem in the body’s germ-fighting complement system. Testing can also help when this runs in the family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies depending on the condition and the type of variant involved. Over time, the way your body works is also shaped by factors such as age, environment, lifestyle, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the C7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how well medicines will work or which side effects may happen, so any questions about treatments, side effects, or medication changes are best discussed with your doctor.
History
The C7 gene entered medical genetics through studies of families with repeated meningococcal infections, which led researchers in the 1970s and 1980s to identify inherited C7 deficiency. Early work first focused on the C7 protein in the blood, and later linked the pattern to changes in the C7 gene itself. Initially understood only through visible traits, later recognized as tied to a specific gene, this shift helped connect complement deficiencies with inherited infection risk. From these first observations, research expanded steadily. As DNA methods improved, clinicians could confirm C7-related deficiency more directly and separate it from other terminal complement component deficiencies. That work placed the C7 gene within the broader history of immune system genetics and rare inherited susceptibility to certain bacterial infections.